Wunder JS - Search Results

1

Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients.

Koster R, Panagiotou OA, Wheeler WA, Karlins E, Gastier-Foster JM, Caminada de Toledo SR, Petrilli AS, Flanagan AM, Tirabosco R, Andrulis IL, Wunder JS, Gokgoz N, Patiño-Garcia A, Lecanda F, Serra M, Hattinger C, Picci P, Scotlandi K, Thomas DM, Ballinger ML, Gorlick R, Barkauskas DA, Spector LG, Tucker M, Belynda DH, Yeager M, Hoover RN, Wacholder S, Chanock SJ, Savage SA, Mirabello L. Koster R, et al. Among authors: wunder js. Int J Cancer. 2018 Apr 15;142(8):1594-1601. doi: 10.1002/ijc.31195. Epub 2017 Dec 23. Int J Cancer. 2018. PMID: 29210060 Free PMC article.

2

Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas.

Wunder JS, Czitrom AA, Kandel R, Andrulis IL. Wunder JS, et al. J Natl Cancer Inst. 1991 Feb 6;83(3):194-200. doi: 10.1093/jnci/83.3.194. J Natl Cancer Inst. 1991. PMID: 1988704

3

Molecular genetic changes in musculoskeletal sarcomas.

Wunder JS, Andrulis IL, Czitrom AA. Wunder JS, et al. Chir Organi Mov. 1990;75(1 Suppl):6-8. Chir Organi Mov. 1990. PMID: 2249560 No abstract available.

4

Expression of the multidrug resistance gene in osteosarcoma: a pilot study.

Wunder JS, Bell RS, Wold L, Andrulis IL. Wunder JS, et al. J Orthop Res. 1993 May;11(3):396-403. doi: 10.1002/jor.1100110311. J Orthop Res. 1993. PMID: 8100852

5

Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas.

Wunder JS, Eppert K, Burrow SR, Gokgoz N, Bell RS, Andrulis IL. Wunder JS, et al. Oncogene. 1999 Jan 21;18(3):783-8. doi: 10.1038/sj.onc.1202346. Oncogene. 1999. PMID: 9989829

6

Molecular alterations in bone and soft-tissue sarcoma.

Bell RS, Wunder J, Andrulis I. Bell RS, et al. Can J Surg. 1999 Aug;42(4):259-66. Can J Surg. 1999. PMID: 10459325 Free PMC article. Review.

7

Expression of osteocalcin and its transcriptional regulators core-binding factor alpha 1 and MSX2 in osteoid-forming tumours.

Hopyan S, Gokgoz N, Bell RS, Andrulis IL, Alman BA, Wunder JS. Hopyan S, et al. Among authors: wunder js. J Orthop Res. 1999 Sep;17(5):633-8. doi: 10.1002/jor.1100170503. J Orthop Res. 1999. PMID: 10569470

8

MDR1 gene expression and outcome in osteosarcoma: a prospective, multicenter study.

Wunder JS, Bull SB, Aneliunas V, Lee PD, Davis AM, Beauchamp CP, Conrad EU, Grimer RJ, Healey JH, Rock MJ, Bell RS, Andrulis IL. Wunder JS, et al. J Clin Oncol. 2000 Jul;18(14):2685-94. doi: 10.1200/JCO.2000.18.14.2685. J Clin Oncol. 2000. PMID: 10894867

9

p53 missense but not truncation mutations are associated with low levels of p21(CIP1/WAF1) mRNA expression in primary human sarcomas.

Mousses S, Gokgoz N, Wunder JS, Ozcelik H, Bull S, Bell RS, Andrulis IL. Mousses S, et al. Among authors: wunder js. Br J Cancer. 2001 Jun 15;84(12):1635-9. doi: 10.1054/bjoc.2001.1844. Br J Cancer. 2001. PMID: 11401317 Free PMC article.

10

Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma.

Gokgoz N, Wunder JS, Mousses S, Eskandarian S, Bell RS, Andrulis IL. Gokgoz N, et al. Among authors: wunder js. Cancer. 2001 Oct 15;92(8):2181-9. doi: 10.1002/1097-0142(20011015)92:8<2181::aid-cncr1561>3.0.co;2-3. Cancer. 2001. PMID: 11596036

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

349 results

Search Page